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ABSTRACT 
 
The β-adrenergic agonist ractopamine is increasingly used in the swine industry due to higher consumer demand for 
leaner pork products. Redirecting nutrients to favor leanness rather than fat deposition, ractopamine improves 
growth and carcass traits of finishing pigs. However, the impact of this agonist on pork quality is not clearly 
defined. Understanding the biological effects of dietary ractopamine dose, treatment period, lysine levels, and the 
lysine to metabolizable energy ratio will help pork producers achieve improvements in animal performance, carcass 
leanness, and economic efficiency in swine production systems.  
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INTRODUCTION 
 
Pork is the most widely consumed form of animal 
protein in the world, but the consumption of pork 
products remains low in Brazil. Brazilian per 
capita pork consumption was only 14.24 kg in 
2009 (ABIPECS 2011), which is much lower than 
in the European Union, where it was 42.80 kg in 
the same year (USDA 2011). The main reason for 
low Brazilian pork consumption may be related to 
lingering myths and beliefs concerning the 
possible negative effects of pork consumption on 
human health. 
Consumer demand for leaner and healthier pork 
products has risen steadily each year; thus, 
improvements in animal health, genetics, and 
especially nutritional technologies, such as the 
utilization of β-adrenergic agonists in diets, have 
become important in helping pork producers to 
meet this demand. In addition to their use in 
human and veterinary medicine as bronchodilatory 
and tocolytic agents (Kuiper et al. 1998), β-
adrenergic agonists increase both lean growth rate 
and carcass lean percentage (Boler et al. 2010), 
and improve feed efficiency of finishing pigs 
(Rikard-Bell et al. 2009; Hinson et al. 2011). 
Ractopamine is classified as a β-adrenergic agonist 
that acts as a repartitioning agent, redirecting 
nutrients away from adipose tissue and towards 
greater muscle deposition. Its use has obtained 
regulatory approval as a growth-promoting feed 
additive for swine in the United States, Canada, 
and Brazil. However, ractopamine is not 
authorized for use in the European Union or China 
for growth promotion in farm animals.  
The objectives in this review are to highlight the 
current state of knowledge regarding the 
modulation of animal growth by ractopamine and 
to define strategies for optimizing finishing pig 
responses. 
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Chemical structure of ractopamine 
Ractopamine is a phenylethanolamine with β-
adrenergic agonist properties similar to the natural 
catecholamines epinephrine and norepinephrine. 
The presence of an aromatic ring with a hydroxyl 
group bound to the β-carbon, positively charged 
nitrogen in the ethylamine side chain, and bulky 
substituent (butyl-phenol group, Fig. 1) on the 
aliphatic nitrogen makes the molecule more 
specific to the β-adrenergic receptor (βAR) (Smith 
1998). Two conformations can arise at each chiral 
carbon (R or S); therefore, the commercial 
preparation of ractopamine is an equimolar 
mixture of four stereoisomers (RR, RS, SR, and 
SS) (Ricke et al. 1999). 
 
 
Figure 1 - Chemical structure of ractopamine. Asterisks indicate the locations of the chiral carbons 
(Modified from Ricke et al. 1999). 
 
 
β-adrenergic receptor tissue distribution and 
ractopamine isomers 
Most mammalian cell types have βAR embedded 
in the plasma membrane. These receptors can be 
classified into three subtypes: β1AR, β2AR, and 
β3AR (Lands et al. 1967). The predominant 
subtype expressed in pig tissues is β1AR, 
representing 73% of the total βAR in adipose 
tissue (McNeel and Mersmann 1999) and 59% in 
skeletal muscle (Liang and Mills 2002). Porcine 
skeletal muscle contains 41% β2AR (Liang and 
Mills 2002), while 20% appears in porcine 
adipocytes (McNeel and Mersmann 1999). 
However, there is a limited pattern of β3AR 
expression in most tissues except adipose, where it 
constitutes 7% of βAR mRNA abundance 
(McNeel and Mersmann 1999).  
Ractopamine is a mixture of four stereoisomers, 
but not all isomers may be biologically active, and 
the correct kinetics of the active isomer may be 
confounded by the presence of competing isomers 
(Ricke et al. 1999). The RR isomer is likely the 
functional ligand of ractopamine, but its 
effectiveness may be compromised by the 
presence of the RS stereoisomer (Mills et al. 
2003a). Moreover, in the cloned receptor model, 
RR stereoisomers may couple more efficiently to 
adenyl cyclase through β2AR rather than β1AR, 
even though it exhibits equal affinity to both 
subtypes (Mills et al. 2003a). 
 
 
β-adrenergic receptor signaling pathway 
The transmembrane signaling pathway is initiated 
by ractopamine binding to βAR, which activates 
the guanine nucleotide-binding protein (G 
protein). G proteins are heterotrimers that consist 
of the Gα and the tightly associated Gβγ subunits; in 
its inactive form, the Gα subunit is coupled with 
guanosine diphosphate (GDP) (Benovic 1988). 
Binding of β-agonists to βAR leads to the 
activation of the G protein-coupled receptor; the 
Gα subunit releases GDP and binds to guanosine 
triphosphate (GTP) to activate the subunit. The Gα 
subunit then dissociates from the Gβγ dimer and 
activates adenyl cyclase (AC), which catalyzes the 
conversion of adenosine triphosphate (ATP) into 
cyclic adenosine monophosphate (cAMP) (Alberts 
et al. 2004). The cAMP then binds to the 
regulatory subunits of cAMP-dependent protein 
kinase A (PKA), causing a conformational change 
that releases and activates the catalytic subunits 
(Benovic 1988). These activated subunits can then 
phosphorylate various enzymes to mediate cellular 
responses (Fig. 2). 
With prolonged exposure of the cells to 
ractopamine, the intensity of the receptor-mediated 
response can be reduced despite the continued 
presence of the agonist. This diminished 
responsiveness, termed desensitization, can occur 
by three main processes: (1) uncoupling of the  
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receptors from its G protein, (2) temporary 
sequestration and internalization of uncoupled 
receptors, and (3) degradation of internalized 
receptors (Alberts et al. 2004). Desensitization can 
be divided into uncoupling and down-regulation 
responses (Mills 2002b).  
 
 
 
Figure 2 - Intracellular signaling pathways for the β-adrenergic receptor. β, β-adrenergic receptor; 
γ/β, γ and β subunits of the G protein; Gα, α subunit of the G protein; GTP, guanosine 
triphosphate; AC, adenyl cyclase; ATP, adenosine triphosphate; cAMP, cyclic 
adenosine monophosphate; PKA, cAMP-dependent protein kinase A; E, enzyme; and 
EPO4, phosphorylated enzyme (Modified from Barros et al. 1999). 
 
 
 
Uncoupling is initiated within seconds to minutes 
following agonist exposure and involves 
phosphorylation of βAR by PKA, β-adrenergic 
receptor kinase 1 (βARK1), or both (Johnson 
2006). Upon agonist stimulation, the βARK1 
association with the plasma membrane is 
facilitated by binding to Gβγ subunits (Mills 
2002b). The receptor-agonist complex has a high 
affinity for βARK1, resulting in the 
phosphorylation of activated βAR, which 
facilitates the inhibitor protein β-arrestin binding 
and uncoupling from G protein (Ungerer et al. 
1996). Subsequently, βAR bound to β-arrestin is 
sequestered away from the plasma membrane 
surface and internalized into cytoplasmic vesicles 
(Lhose et al. 1990). The receptor is then 
dephosphorylated, β-arrestin dissociates, and βAR 
is recycled back to the membrane (Fig. 3). 
Depending upon the duration of agonist exposure, 
which can last for hours to days, internalized βAR 
are destroyed, resulting in a net loss of available 
membrane receptors. During this process, which is 
called down-regulation, βAR is ubiquitinated by 
E3 ubiquitin-protein ligase which activates the 
process of receptor degradation in the lysosomes 
(Johnson 2006). Both processes, uncoupling and 
down-regulation, contribute to a reduction in total 
βAR in the plasma membrane (Mills 2002b). 
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Figure 3 - β-adrenergic receptor desensitization and resensitization. β, β-adrenergic receptor; α, α 
subunit of the G protein; γ/β, γ and β subunits of the G protein; GTP, guanosine 
triphosphate; cAMP, cyclic adenosine monophosphate; PKA, cAMP-dependent protein 
kinase A; βARK1, β-adrenergic receptor kinase 1; P, phosphorylation; and β-Arr, β-
arrestin (Modified from Barros et al. 1999). 
 
 
Metabolic responses induced by ractopamine 
The main effect of feeding ractopamine to pigs is 
muscle cell hypertrophy that enhances lean mass, 
which may result from increased muscle protein 
synthesis, decreased protein degradation, or both 
(Mersmann 1998). Bergen et al. (1989) observed 
daily increases in fractional protein synthesis rates 
from 4.4 to 6.1% in muscle of pigs fed 20 ppm 
ractopamine. Similar results were reported by 
Grant et al. (1993), in which α-actin mRNA 
abundance was increased by feeding ractopamine 
to pigs. Ractopamine also increased the 
proliferation of chick satellite cells in culture 
(Grant et al. 1990), but the recruitment of 
additional satellite cell nuclei does not appear to 
be a prerequisite for the accelerated accretion of 
skeletal muscle because DNA concentrations were 
not enhanced with ractopamine supplementation 
(Grant et al. 1993). On the other hand, the 
hypertrophic effect of ractopamine may be the 
result of a decreased rate of muscle protein 
degradation, as calpain I activity was reduced in 
the muscles of pigs fed 20 ppm ractopamine for 
three weeks prior to slaughter (Sainz et al. 1993). 
Moreover, the repartitioning of energy by 
ractopamine can increase blood flow to skeletal 
muscle, supporting the idea that β-adrenergic 
agonists could readily enhance the process of 
hypertrophy by increasing the provision of 
substrates and energy sources for protein synthesis 
(Mersmann 1998).  
Reductions in plasma urea concentrations have 
also been reported in pigs fed ractopamine. 
According to See et al. (2004), a decline in the 
circulating plasma urea concentration results from 
an increase in muscle protein synthesis promoted 
by ractopamine, which consequently elevates 
nitrogen utilization. The reduction in plasma urea 
occured within 30 hours of ractopamine feeding, 
and its withdrawal caused a marked increase 
(21%) circulating plasma urea nitrogen (Dunshea 
and King 1994). Pigs receiving 5 ppm ractopamine 
showed a decrease of 12% in plasma urea 
concentrations within 14 days of feeding, but not 
within 28 days; thus, the agonist may act more 
efficiently on protein metabolism during the first 
14 days of supplementation (Cantarelli et al. 
2009a). 
In adipocytes, stimulation of βAR by ractopamine 
promotes an increase in lipolysis and an inhibition 
of fatty acids and triacylglycerol synthesis 
(Mersmann 1998), the opposite of insulin action, 
which stimulates lipogenesis in swine adipose 
tissue. Under appropriate in vitro conditions, Liu 
and Mills (1990) found that ractopamine can 
inhibit insulin binding in approximately 10%; 
ractopamine therefore antagonizes insulin action in 
pig adipocytes. Additionally, ractopamine 
supplementation at 20 ppm interacts in vivo with 
the βAR of swine adipocytes, suppressing the 
activity of lipogenic enzymes and the capacity for 
de novo fatty acid synthesis (Mills et al. 1990). 
Direct activation of βAR in pig adipose tissue by 
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ractopamine stimulated the in vitro release of 
glycerol and free fatty acids through increased 
lipolysis (Peterla and Scanes 1990).  
The oral administration of ractopamine to pigs 
promoted lower fat accretion due to an attenuation 
of lipogenesis (Bergen 2001). Likewise, recent 
studies focusing on lipogenic gene expression 
have indicated that ractopamine reduces the 
expression of lipid synthesis genes, such as sterol 
regulatory element binding protein-1 (SREBP-1) 
and fatty acid synthase (FAS), in the adipose tissue 
of finishing pigs (Reiter et al. 2007; Halsey et al. 
2011). Furthermore, the expression of peroxisome 
proliferator-activated receptor γ2 (PPARγ2), a 
transcription factor involved in adipogenesis, was 
decreased when pigs were fed ractopamine for 28 
and 42 days (Halsey et al. 2011). Thus, lipolysis 
may not be the primary contributor to decrease fat 
deposition in ractopamine-fed pigs. Ractopamine 
can also trigger the apoptotic process in mouse 
adipose tissue (Page et al. 2004), which may 
partially explain the reduction in carcass fat of 
pigs (Weber et al. 2006).  
Ractopamine has been evaluated for possible 
effects on animal welfare. As suggested by 
Schaefer et al. (1992), the utilization of 
ractopamine in swine finishing diets did not cause 
marked changes in animal behavior even though 
pigs spent more time lying and less time walking 
during a 4-hour period. In contrast, Marchant-
Forde et al. (2003) observed that pigs fed 10 ppm 
ractopamine for four weeks were more active and 
had elevated heart rates and circulating 
catecholamine levels, making them more difficult 
to handle and potentially more susceptible to stress 
during handling and transport. Gilts demonstrated 
increased aggressiveness, and ractopamine appears 
to intensify this behavior (Poletto et al. 2010). 
 
Modulation of lipid metabolism by ractopamine 
Ractopamine may have a direct effect on porcine 
lipid metabolism due to both increased lipolysis 
(Fain and García-Sáinz 1983; Peterla and Scanes 
1990) and reduced lipogenesis (Bergen 2001; 
Reiter et al. 2007; Halsey et al. 2011). However, 
reductions in fat deposition induced by 
ractopamine have not been clearly observed 
(Dunshea et al. 1993, 1998; Carr et al. 2005b; 
Fernández-Dueñas et al. 2008; Moore et al. 2009; 
Boler et al. 2010; Kutzler et al. 2010). Because 
literature reports regarding the effects of 
ractopamine on fat accretion are inconclusive, in 
vitro assays were developed to explain the possible 
irresponsiveness of ractopamine in adipose tissue 
metabolism. Mills (2000) suggested that β1AR is 
the major regulator of lipolysis in pigs and that 
β2AR may not be linked to the lipolytic cascade, 
possibly due to intracellular compartmentalization. 
Despite β1AR being the predominant subtype in 
swine adipocytes, the RR isomer might 
preferentially target β2AR, and ractopamine may 
therefore have limited effectiveness in reducing fat 
accretion in pigs (Mills et al. 2003a). Mills et al. 
(2003b) demonstrated that stimulation of lipolysis 
by the RR isomer was mediated predominantly 
through β2AR, thus making it a full agonist 
through this receptor. However, both β1AR and 
β2AR contributed to the stimulation of lipolysis by 
RR in swine adipocytes, because β2AR 
intracellular compartmentalization was not 
confirmed. As a result, a molecule with full 
agonist activity through β1AR could likely 
promote greater reductions in fat accretion (Mills 
et al. 2003b). 
Besides the distribution patterns of βAR subtypes 
in porcine adipose tissue as previously mentioned, 
chronic ractopamine feeding can compromise the 
reduction in adipose deposition. Prolonged 
exposure to ractopamine progressively decreased 
βAR in the subcutaneous adipose tissue of pigs by 
28% within one day and 53% within eight days 
because of the down-regulation of βAR that limits 
ractopamine response in this tissue (Spurlock et al. 
1994). On the other hand, Smith (1989) failed to 
detect down-regulation of βAR in the skeletal 
muscle of ractopamine-fed pigs. This difference 
may indicate that muscle tissue can be a more 
responsive target for ractopamine than adipose 
tissue (Liu et al. 1994), or, perhaps, that 
ractopamine stimulates the synthesis of new βAR 
protein in skeletal muscle, which effectively masks 
down-regulation (Mills 2002b). Choosing a more 
potent agonist, increasing ractopamine dose, or 
using treatment regimens that circumvent agonist-
induced receptor down-regulation could have an 
enhanced capacity to reduce lipid accretion (Liu et 
al. 1994). 
 
Ractopamine: growth performance and carcass 
traits of finishing pigs 
Ractopamine is able to produce maximum lean 
gain at a low energy intake by repartitioning 
energy for maximal protein deposition (Williams 
et al. 1994). These authors further observed that an 
energy intake above 8.3 Mcal of metabolizable 
energy per day (ME/d) for barrows and 7.7 Mcal 
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of ME/d for gilts was deposited as fat. However, a 
recent study demonstrated that ractopamine 
supplementation resulted in enhanced lean 
deposition regardless of dietary energy levels 
(Hinson et al. 2011). Furthermore, the lysine to 
metabolizable energy ratio (Lys:ME) may impact 
performance and carcass characteristics in 
ractopamine-fed pigs more than absolute energy 
intake values (Apple et al. 2004). These authors 
concluded that 3.30 Mcal of ME/kg are enough to 
optimize lean tissue deposition in pigs fed 10 ppm 
ractopamine and that both performance and 
carcass traits improved as the Lys:ME ratio 
increased from 1.7 to 3.1 g/Mcal. Likewise, the 
addition of 10 ppm ractopamine to pig diets 
containing 3.1 g/Mcal Lys:ME and 3.48 Mcal of 
ME/kg improved rate and efficiency of gain, 
carcass leanness, and meat quality (Apple et al. 
2008).  
It has been repeatedly shown that including 
ractopamine in swine finishing diets improves feed 
efficiency (Webster et al. 2007; Apple et al. 2008; 
Main et al. 2009; Poletto et al. 2009; Rikard-Bell 
et al. 2009; Edmonds and Baker 2010; Hinson et 
al. 2011). Because less dietary energy is required 
to deposit muscle tissue in comparison with 
adipose tissue, ractopamine-treated pigs present 
enhanced growth rates and efficiencies of gain 
(Schinckel et al. 2003). 
In a meta-analysis involving dietary levels of 
ractopamine (0, 5, 10, and 20 ppm), Kiefer and 
Sanches (2009) observed quadratic improvements 
in average daily gain and feed to gain ratio as the 
inclusion of ractopamine increased in the diets of 
finishing pigs, concluding that 15 ppm 
ractopamine optimized animal performance. 
However, performance enhancements in modern 
high-lean-gain pigs are achieved efficiently with 
just 5 ppm ractopamine (Schinckel et al. 2002). 
One of the most important things to consider 
regarding the utilization of ractopamine is that the 
response is not constant over time. Williams et al. 
(1994) showed that maximum growth response 
occurred during the first three weeks of 
ractopamine feeding, while Mills (2002a) 
observed that the agonist response was greater 
during the first week of utilization and decreased 
as the program extended from four to six weeks. 
This effect occurs when ractopamine is fed at a 
constant level over long periods, as a result of 
down-regulation, desensitization of βAR, or both. 
Therefore, implementing feeding strategies may 
enhance the ability of response to ractopamine 
supplementation (Table 1).  
Implementation of a ractopamine step-up feeding 
regimen (i.e., ractopamine concentrations 
increasing over time) enhances average daily gain 
and feed efficiency of pigs (Poletto et al., 2009). 
Similarly, previous reports from See et al. (2004) 
indicated that ractopamine step-up or constant 
feeding programs resulted in greater benefits in 
live-animal performance, and yielded more lean 
pork in comparison with a step-down feeding 
regimen (i.e., decreasing dietary concentrations of 
ractopamine throughout the feeding period). 
Moreover, Jacela et al. (2009) proposed that 
feeding ractopamine to pigs at a constant level of 
4.5 ppm during the last 21 days prior to market is 
ideal for growth performance, but if pigs could not 
be marketed in a timely manner, then it is 
recommended to increase dietary levels of 
ractopamine.  
Because ractopamine increases protein deposition, 
the percentage of protein accretion deposited in 
muscle tissues increases from 54.0 to 59.4, 60.3, 
and 61.65%, and the lysine content of the protein 
accretion increases from 6.80 to 7.05, 7.09, and 
7.15% as ractopamine concentration increases 
from 0 to 5, 10, and 20 ppm, respectively 
(Schinckel et al. 2003). Consequently, pigs 
receiving ractopamine require increased amounts 
of limiting amino acids, especially lysine. Protein 
tissue deposition is the only major function of 
lysine in the animal body, thus its requirement is 
not influenced by other metabolic roles. 
Finishing pigs fed ractopamine require at least 
0.88% dietary digestible lysine to optimize growth 
performance, carcass traits, and tissue accretion 
(Webster et al. 2007). Marinho et al. (2007) 
reported improved performance of finishing pigs 
fed ractopamine with diets containing 0.67% 
digestible lysine; however, with 0.87% digestible 
lysine, pigs showed decreased backfat thickness 
and increased carcass lean percentage, loin depth, 
and lean meat deposition. Pigs receiving diets 
containing low crude protein (12.5%) and lysine 
(0.49%) levels for 14 days, followed by a 
subsequent 21-day period receiving higher crude 
protein (20.33%) and lysine (0.99%) levels, can 
recover and present similar growth performance 
and carcass merit in comparison with those in a 
conventional protein feeding regimen (Edmonds 
and Baker 2010). When developing a model of 
dietary lysine requirements for ractopamine-fed  
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pigs, Schinckel et al. (2001) concluded that the 
predicted lysine requirement for pigs quickly 
increases during the first week of ractopamine 
feeding and then declines; thus, pork producers 
should consider phase feeding with two or three 
diets containing different lysine levels. According 
to Schinckel et al. (2006), step-up programs can 
enhance the duration of ractopamine response, but 
only if dietary lysine levels are increased. In 
addition, the greatest economic benefit from 
ractopamine step-up programs is achieved when 
producers receive carcass premiums (Canchi et al. 
2009). 
 
Table 1 - Effects of ractopamine feeding strategies on growth performance and carcass traits of finishing pigs   
Reference Ractopamine Feeding Strategies Sex 
Performance1 Carcass Trait2 
FBW  
(kg) 
ADFI 
(kg) 
ADG 
(kg) G:F F:G 
LMA 
(cm2) 
10th-rib 
fat depth 
(cm) 
See et al. 
(2004) 
0 ppm for 41 d  109.60 2.98 0.930b 0.310b - 43.40c 1.47a 
5 ppm for 14 d, 10 ppm for 14 d and 20 
ppm for 13 d 
barrows 
and gilts 111.80 2.75 1.000
a
 0.360ª - 50.50a 1.07b 
20 ppm for 14 d, 10 ppm for 14 d and 5 
ppm for 13 d 111.20 2.78 1.000
a
 0.360ª - 47.30b 1.09b 
11.7 ppm for 41 d 113.00 2.75 1.000a 0.360a - 49.40ab 1.17b 
 
 
        
Armstrong 
et al. 
(2005) 
0 ppm for 35 d  102.70b 2.25 0.700a - 3.24a - 1.65 
5 ppm for 35 d barrows 
and gilts 
105.30ª 2.27 0.760b - 3.00b - 1.60 
5 ppm for 14 d and 10 ppm for 21 d 106.50ª 2.25 0.800c - 2.82c - 1.63 
5 ppm for 21 d and 10 ppm for 14 d 106.90ª 2.29 0.810c - 2.82c - 1.57 
          
Jacela et 
al. (2009) 
0 ppm for 28 d  114.76 2.69 0.798a - 3.39a - 1.73a 
0 ppm for 7 d and 4.5 ppm for 21 d barrows 
and gilts 
118.98 2.68 0.948b - 2.82b - 1.68a 
4.5 ppm for 14 d and 6.75 ppm for 14 d 118.71 2.59 0.929b - 2.79b - 1.57b 
          
Moore et 
al. (2009) 
0 ppm for 26 d immunocastrated  
males 115.00
b
 3.89 1.200b - 3.26a - 1.53 
5 ppm for 26 d 
 
116.30a 3.62 1.270a - 2.87b - 1.43 
5 ppm for 14 d and 10 ppm for 12 d 117.40a 3.75 1.300a - 2.91b - 1.45 
          
Poletto et 
al. (2009) 
0 ppm for 28 d barrows 
and gilts 
117.84b 2.97 0.898b 0.307b - - - 
5 ppm for 14 d and 10 ppm for 14 d 122.58ª 2.91 1.044ª 0.358ª - - - 
          
Rikard-
Bell et al. 
(2009) 
0 ppm for 31 d immunocastrated  
males 108.40
b
 3.65 1.240b 0.339b - - - 
5 ppm for 14 d and 10 ppm for 17 d 
 109.90a 3.43 1.270a 0.370a - - - 
 
         
Neill et 
al. (2010) 
0 ppm for 56 d  120.40b 2.87 0.940b 0.330b - - - 
10 ppm for 21 d and 0 ppm for 35 d barrows 
and gilts 
120.70b 2.85 0.950b 0.330b - - - 
10 ppm for 21 d, 0 ppm for 14 d and 10 
ppm for 21 d 123.40
a
 2.83 1.000a 0.360a - - - 
0 ppm for 35 d and 10 ppm for 21 d 123.80a 2.83 1.000a 0.350a - - - 
1FBW, final body weight; ADG, average daily gain; ADFI, average daily feed intake; G:F, gain:feed ratio (feed efficiency); F:G, 
feed:gain ratio (feed conversion). 
2LMA, Longissimus muscle area.  
a,b,c
 Within a column, means with different superscripts differ (P < 0.05). 
 
 
In the past, pork producers were paid strictly on a 
live-weight basis; thus, little attention was given to 
the composition of gain, which often resulted in 
carcasses with excessive amounts of fat. Today, 
the relative value of carcass lean to carcass fat 
becomes an economically important factor because 
carcass merit pricing and evaluation systems have 
been adopted in the pork industry.  
Cantarelli et al. (2009b) observed a 3.9% increase 
in carcass premiums for pigs supplemented with 5 
ppm ractopamine in comparison with control 
animals. These results are in  agreement with those 
obtained by Corassa et al. (2009), who reported 
that pigs receiving 5 ppm ractopamine produced 
4.9% more meat and had a 2.2% increase in 
carcass premiums when compared to those without 
supplementation. According to Li et al. (2003), the 
positive impact is defined by the payments that 
pork producers receive for lean meat in relation to 
fat tissue and the discount/premium schedules. The 
maximum profit was obtained with ractopamine 
levels of 10 and 12 ppm for the systems of 
revenue/live weight and revenue/carcass premium, 
respectively, but the system of revenue/carcass 
premium was more economically viable (Brumatti 
and Kiefer 2010). The economically optimal 
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management of ractopamine concentrations, 
feeding duration, and lysine levels are therefore 
determined by the economic return for increased 
leanness, including costs of feed and feed 
additives. 
 
Impact of ractopamine on pork quality 
The effects of ractopamine on meat quality in pigs 
have been reported in the literature, but the results 
remain inconsistent and inconclusive. Feeding 
ractopamine to finishing pigs does not have an 
adverse effect on initial pH (45 min postmortem), 
ultimate pH (24 h postmortem), or drip loss (Carr 
et al. 2005a). Other studies have reported that drip 
loss percentage and redness and yellowness of the 
Longissimus dorsi decreased in response to dietary 
ractopamine (Webster et al. 2007; Apple et al. 
2008; Almeida et al. 2010; Kutzler et al. 2010; 
Leick et al. 2010), but Carr et al. (2009) did not 
observe any difference in subjective color score 
when pigs were fed 0, 5, and 20 ppm ractopamine.  
The available literature has established that 
supplementing finishing pig diets with 5, 10, or 20 
ppm ractopamine increases Warner-Bratzler shear 
force values (Carr et al. 2005a, b; Xiong et al. 
2006; Fernández-Dueñas et al. 2008). One 
possible explanation is that ractopamine increases 
muscle calpastatin activity and reduces calpain 
activity; in other words, the reduction in 
postmortem proteolysis of myofibrillar protein 
provides higher shear force values, or reduced 
meat tenderness (Xiong et al. 2006). The accretion 
of fast white fibers, which have larger diameters, 
may contribute to the reduced meat tenderness 
observed with dietary ractopamine 
supplementation (Carr et al. 2005b). Despite the 
fact that ractopamine feeding increased meat 
toughness, the effects may be reduced if pig 
carcasses or carcass cuts are aged for a prolonged 
period, or submitted to other suitable postmortem 
handling and storage conditions (Xiong et al. 
2006).  
 
Ractopamine residues in animal tissues  
The presence of drug residues in the tissues of 
treated animals, especially when the compound 
has been used illegally or in an off-label manner, 
is a concern for food quality and safety. 
Ractopamine has obtained regulatory approval as a 
feed additive in swine production in more than 20 
countries, including the United States, Canada, and 
Brazil. However, this repartitioning drug is 
 
forbidden in the European Union and China due to 
several reported cases of clenbuterol food 
poisoning (Kuiper et al. 1998; Qiang et al. 2007). 
Ractopamine residues found after the 
discontinuation of exposure have been reported for 
cattle and sheep (Smith and Shelver 2002). This 
study showed that ractopamine may be detected 
for at least seven or five days after the last 
exposure in the urine of sheep and cattle, 
respectively. 
In a depletion study, Qiang et al. (2007) measured 
ractopamine residues in the tissues of pigs after 
administration of 20 ppm dietary ractopamine for 
28 days. These authors reported that while 
residues in muscle and fat were not detectable 24 
hours after the last agonist exposure, residues in 
kidney remained higher than those in liver 
throughout the withdrawal period. Ractopamine 
concentrations in liver, kidney, muscle, and fat 
tissues of pigs during the withdrawal period were 
lower than the tolerance values established by the 
Food and Drug Administration (FDA) and the 
Maximum Residue Levels (MRL) listed by the 
Joint FAO/WHO Expert Committee on Food 
Additives (JECFA).  
In order to monitor the illegal use of ractopamine, 
it is necessary to develop proper residue detection 
methods in swine tissues, feeds, and urine. Recent 
researches have suggested instrumental methods to 
detect these residues (Sakai et al. 2007; Shen et al. 
2007; Zhang et al. 2009; Zhai et al. 2011), but no 
mention of ractopamine-withdrawal period for 
finishing pigs were made. In this way, further 
studies are required to determine whether 
consumer safety can be assured without applying a 
ractopamine-withdrawal period. 
 
 
CONCLUSION  
 
The β-adrenergic agonist ractopamine has been 
increasingly used in the swine industry due to its 
ability to improve performance and carcass 
leanness, resulting in enhanced opportunities for 
improving the profitability of producers. In 
comparison with constant and step-down 
programs, greater animal responses to ractopamine 
step-up programs have been reported; however, 
pork producers should consider implementing this 
feeding strategy when lean carcasses are rewarded. 
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